Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
|
|
|
Definition of sympathomimetic
|
Drugs that partially or completely mimic the actions of NE (norepinephrine, noradrenaline) or epinephrine (adrenaline)
|
|
Catecholamines include __, __, and __.
|
"Include NE, epinephrine, dopamine and isoproterenol.
|
|
What is the structural difference between catecholamines and non-catecholamines?
|
C - have benzene ring with two alcohols in their structure. NC - have benzene ring with substitutions in place of the alcohols.
|
|
What does the presence of a large alkyl group on a catecholamine indicate re: beta receptor activity?
|
Large alkyl group indicates greater beta receptor activity.
|
|
Directly acting SYMmims stimulate which adrenergic receptors?
|
Alpha-1, alpha-2, beta-1, and beta-2.
|
|
Clonidine, Brimonidine"
|
"
|
|
Epinephrine"
|
"
|
|
Terbutaline, albuterol, ritodrine"
|
"
|
|
Epinephrine has affinity for what adrenoreceptors? It shows a __ __ effect?
|
Affinity for all adrenoreceptors. There is a dose response effect.
|
|
__ receptors show more effect from epi at lower doses. The result is vasodilation. What do higher levels of epi show? By which receptor are higher concentrations processed?
|
Beta-2 receptors. Higher levels constrict all blood vessels, processed by the alpha receptors.
|
|
How does NE affect TPR and BP? Does it have the same effect on HR? How is the effect on TPR different from other mixed and beta-only agonists?
|
NE increases TPR and BP. HR may decrease because of baroreceptor reflex. EPI and isoproteronol decrease TPR; NE increases it.
|
|
With EPI administration, __ receptors cause BP to increase and HR to decrease.
|
Alpha-1.
|
|
Indirectly acting SYMmims elicit effects similar to NE by __.
|
They stimulate NE release from nerve terminals. NE is taken up by the neuron and produces the effects. The indirect SYMmim does not actually bind to the receptor.
|
|
__ acts via NE release from nerve terminal and therefore, can significantly increase HR and BP via indirect action.
|
|
|
Unlike epinephrine, __ can be give orally? Which receptors does it act on? Is this drug direct or indirect acting?
|
Ephedrine. Acts on alpha-1, alpha-2, beta-1, and beta-2 receptors. Is mixed action (i.e., acts directly and indirectly).
|
|
In general, alpha adrenergic receptors control __, while beta adrenergic receptors control __.
|
Constriction. Dilation.
|
|
Urinary Bladder"
|
"Predominant Tone at Rest
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: HEART.
|
Beta-1 receptor. Increased SYM. Decreased PSYM. M2 >> M3.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: EYE - pupil size.
|
Alpha-1. SYM - mydriasis. PSYM - miosis. M3, M2.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: EYE - accomodation.
|
SYM - minimal effect. PSYM - contraction/accomodation for near vision. M3, M2.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: EYE - secretion of aqueous humor.
|
Beta; SYM - increases production and pressure; PSYM - Increases outflow/decreases pressure. Alpha-2; SYM decreases pressure/increases outflow. M3, M2.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: BLOOD VESSELS IN THE VISCERA, SKIN, LUNGS.
|
Alpha-1, alpha-2. SYM - constriction. PSYM - 0.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: RENAL VESSELS.
|
Alpha-1, alpha-2; SYM - constriction. No PSYM.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: SKELETAL MUSCLES.
|
Alpha-1. SYM - constriction. PSYM - dilation. Beta-2. Dilation (low dose EPI). No PSYM.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: CORONARY VESSELS.
|
Alpha-1, alpha-2. SYM - constriction. PSYM - 0. Beta-2. SYM - dilation. PSYM - 0.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: VEINS
|
Alpha-1. SYM - constriction. PSYM - 0.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: BRONCHIAL SMOOTH MUSCLE.
|
Beta-2 receptor. SYM - relaxation (bronchodilation) PSYM - contraction. M2=M3.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: SWEAT GLANDS.
|
Alpha-1. SYM - localized sweating. PSYM - generalized sweating. M3, M2.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: GIT.
|
"Gastrointestinal Tract
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: URINARY BLADDER.
|
SMOOTH M. WALL: Beta-2; SYM - slight relaxation; PSYM - slight contraction. SPHINCTER: Alpha-1; SYM - Contraction. PSYM - Relaxation. M3>M2.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: PREGNANT UTERUS.
|
Beta-2; SYM - Relaxation. PSYM - 0. Alpha-1; SYM - Contraction; No PSYM.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: PENIS.
|
Alpha-1. SYM - ejaculation. PSYM - ejaculation. M3.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: LIVER.
|
Alpha-1 beta-1. SYM - gluconeogenesis.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: ADIPOSE TISSUE.
|
Alpha-1, beta2, beta 3. SYM - lipolysis.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: KIDNEY.
|
Beta-1. SYN - renin released.
|
|
For this organ, give the predominant adrenergic receptor, SYM and PSYM responses, and the predominant cholinergic receptor: ISLETS.
|
Alpha-1. SYM - decreased insulin.
|
|
"
|
Brimonidine.
|
|
"
|
Amphetamines.
|
|
"
|
Clonidine.
|
|
What are the side effects of SYMmims?
|
Palpitations, anxiety, headaches, N/V, injection site necrosis, sweating.
|
|
SYMmims have dangerous effects when they interact with what drugs?
|
MAOIs, TCAs,
|
|
Dopamine is a naturally occurring precursor to __ and __. What is the receptor affinity? What are the three mechanisms of action for dopamine? Does it cross the BBB?
|
NE and EPI. D1=D2>>B1>>a1. Decreases NE release, interactions with alpha-1 and beta-1 receptors, and peripheral dopamine receptors. Does not cross the BBB.
|
|
__ leads to arterial vasodilation in vascular beds with D1 receptors. It is short-acting and has less side effects.
|
Fenoldopam.
|
|
__ acts directly on the beta-1 adrenoceptors of the heart but it also stimulates beta-2 receptors of the heart. What is the effect on CO, SV, and HR?
|
Dobutamine. Increases CO and SV without a marked increase in HR.
|